The global lipid disorders market is estimated to grow at a significant rate, states Transparency Market Research, in its recent report. The analysis on lipid disorders projects the market of lipid disorder treatment is likely to reach around worth of US$40 bn by the end of year 2026. Development of the global market is pushed by advancement in the treatment for lipid digestion disorders. Organizations associated with lipid disorder treatments are vigorously putting resources into resource and development work of novel medications to bring down cholesterol levels, which helps in diminishing rate of lipid disorders. Organizations operating in the global market incorporate Novartis AG, Pfizer, Inc., Astrazeneca Plc, Emcure Pharmaceuticals Ltd., Merck and Co., and Ranbaxy Laboratories Ltd.
The global market for lipid disorder treatment is expected to grow at a steady CAGR of 7.4% within the forecast period from 2017 to 2026. Various biopharma organizations are concentrating on developing a creative solution in order to treat lipid disorders. Regionally, North America is likely to lead the market rising cases of several medications for lipid disorder treatment. The mentioned region have high market engaging properties which can be credited to increased rates of various lipid disorders and related cardio vascular ailments.
Increase in Level of Triglyceride to Fuel Market Growth
Market for lipid disorder treatment is to a great extent impacted by developing occurrences of disorders related with LDL and rise in triglyceride level in human body. Lipid disorders are to a great extent seen among working people over the globe, which is caused because of less body developments, failed weight control plans, immobile activity and poor lifestyle and habits, for example, excessive smoking and drinking that bring about rise in cholesterol level. This has set off the utilization of different medications, for example, lescol or fluvastatin, atorvastatin, simvastatin, and rosuvastatin to cure lipid disorders as they control and diminish the level of triglycerides and harmful cholesterol in the blood. The global market for lipid disorder treatment is experiencing a growth, offering the producers potential scope in future for distribution and advancement of these medications in the coming years.
Players Have Started Investing in upgrading Products
As there seems to be a rise in the cases of lipid disorders in people, pharmaceutical organizations have started upgrading their drugs, and launch of new medications and initiating phase trials of these medications on an expansive scale. Statins are thought to be immensely powerful in bringing down the rate of cardiovascular episodes. Most organizations are concentrating on large scale manufacturing of atorvastatin as they are an exceedingly powerful less density lipoprotein lowering compounds, LDL being the primary driver of lipid disorders and related heart ailments. The utilization of atorvastatin is estimated to develop at a higher rate.
This analysis is based on a recent market research report by Transparency Market Research, titled, “Lipid Disorder Treatment Market (Drug Type- Atorvastatin, Fluvastatin, Rosuvastatin, Simvastatin, Pravastatin, and Other Drugs; Distribution Channel- Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies; Indication- Familial Combined Hyperlipidemia, Familial Defective Apolipoprotein B-100, Familial Dysbetalipoproteinemia, Familial Hypertriglyceridemia, Heterozygous Familial Hypercholesterolemia, and Other Indications) - Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 – 2026.”
- Market for lipid disorder treatment is to a great extent impacted by developing occurrences of disorders related with LDL and rise in triglyceride level in human body.
- Lipid disorders are to a great extent seen among working people over the globe, which is caused because of less body developments, and poor lifestyle and habits, for example, excessive smoking and drinking that bring about rise in cholesterol level. This has set off the utilization of different medications.
The global lipid disorder treatment market has been segmented as below:
Lipid Disorder Treatment Market – by distribution channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Lipid Disorder Treatment Market – by drug type
Lipid Disorder Treatment Market – by region
- North America
- Latin America
- Rest of Latin America
- Rest of Europe
- Asia Pacific (APAC)
- Australia & New Zealand
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- GCC Countries
- South Africa
- North Africa
- Rest of Middle East and Africa (MEA)
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC